Correlation Between Skye Bioscience, and Alvarium Tiedemann

Can any of the company-specific risk be diversified away by investing in both Skye Bioscience, and Alvarium Tiedemann at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Skye Bioscience, and Alvarium Tiedemann into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Skye Bioscience, Common and Alvarium Tiedemann Holdings, you can compare the effects of market volatilities on Skye Bioscience, and Alvarium Tiedemann and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Skye Bioscience, with a short position of Alvarium Tiedemann. Check out your portfolio center. Please also check ongoing floating volatility patterns of Skye Bioscience, and Alvarium Tiedemann.

Diversification Opportunities for Skye Bioscience, and Alvarium Tiedemann

0.3

Correlation Coefficient

Skye Bioscience,  Alvarium Tiedemann

Weak diversification

The 3 months correlation between Skye and Alvarium is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding Skye Bioscience, Common and Alvarium Tiedemann Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alvarium Tiedemann and Skye Bioscience, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Skye Bioscience, Common are associated (or correlated) with Alvarium Tiedemann. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alvarium Tiedemann has no effect on the direction of Skye Bioscience, i.e., Skye Bioscience, and Alvarium Tiedemann go up and down completely randomly.

Pair Corralation between Skye Bioscience, and Alvarium Tiedemann

Given the investment horizon of 90 days Skye Bioscience, Common is expected to under-perform the Alvarium Tiedemann. In addition to that, Skye Bioscience, is 2.04 times more volatile than Alvarium Tiedemann Holdings. It trades about -0.02 of its total potential returns per unit of risk. Alvarium Tiedemann Holdings is currently generating about 0.12 per unit of volatility. If you would invest  380.00  in Alvarium Tiedemann Holdings on September 4, 2024 and sell it today you would earn a total of  103.00  from holding Alvarium Tiedemann Holdings or generate 27.11% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Skye Bioscience, Common  vs.  Alvarium Tiedemann Holdings

Skye Bioscience, Common

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Skye Bioscience, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Alvarium Tiedemann

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Alvarium Tiedemann Holdings are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite fairly uncertain basic indicators, Alvarium Tiedemann demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Skye Bioscience, and Alvarium Tiedemann

The main advantage of trading using opposite Skye Bioscience, and Alvarium Tiedemann positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Skye Bioscience, position performs unexpectedly, Alvarium Tiedemann can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alvarium Tiedemann will offset losses from the drop in Alvarium Tiedemann's long position.

The idea behind Skye Bioscience, Common and Alvarium Tiedemann Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.